Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Basic aspects of bone metabolic markers]

M Shiraki1, J T Chen, N Kanda

  • 1Research Institute and Practice for Involutional Diseases, Keio University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Clinical characteristics and treatment outcomes in patients with recurrent pericarditis].

Zhonghua xin xue guan bing za zhi·2025
Same author

[Transoral robotic surgery of tonsillar squamous cell carcinoma: analysis of 157 cases from five medical centers].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2025
Same author

[The outcomes of robotic-assisted enucleation for tumors located in uncinate process of pancreas in 16 cases].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2024
Same author

[Advances in the application of prosthetic reconstruction after tumor resection of the distal tibia:a systematic review].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2023
Same author

[The clinical value of oral robotic surgery in the treatment of oropharyngeal squamous cell carcinoma].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2022
Same author

[Application of transoral robotic surgery in treatment of oropharyngeal squamous cell carcinoma].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2022
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Measuring bone metabolic markers like osteocalcin and pyridinoline offers non-invasive insights into bone diseases. Careful interpretation is needed, especially for formation markers in children, considering factors like retarded calcification.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Orthopedics

Context:

  • Metabolic bone diseases significantly alter bone formation and resorption processes.
  • Advancements in measuring bone metabolic markers provide non-invasive methods to assess bone health.
  • Bone-specific proteins and their degradation products serve as indicators of bone matrix turnover.

Purpose:

  • To explore the utility of bone metabolic markers in assessing bone formation and resorption.
  • To highlight specific markers like osteocalcin and carboxy-terminal propeptide of type I collagen (PICP) for osteoblastic function.
  • To discuss the role of urinary pyridinoline and deoxypyridinoline in reflecting bone resorption rates.

Summary:

  • Bone metabolic markers, including osteocalcin and PICP for formation, and urinary pyridinoline/deoxypyridinoline for resorption, are valuable tools.

Related Experiment Videos

  • While useful, interpretation of these markers, particularly formation markers, requires careful consideration of age-related differences and potential dysfunctions like retarded calcification.
  • Osteocalcin shows contrasting correlations with bone mineral density in adults versus height velocity in children.

    • Impact:

    • Provides a framework for understanding and utilizing bone metabolic markers in clinical practice.
    • Emphasizes the need for nuanced interpretation of bone formation markers, considering factors beyond simple levels.
    • Contributes to improved diagnosis and management strategies for metabolic bone diseases by refining marker evaluation.